News | October 06, 2023
Apollo launches Hyderabad's first homecare recovery program
This integrated care offering is a step forward in our vision of providing an effective continuum of care for patients
This integrated care offering is a step forward in our vision of providing an effective continuum of care for patients
This product is bioequivalent to the reference listed drug (RLD), Nexium 24 HR Delayed- Release Capsules, 2.0mg (OTC), of AstraZeneca Pharmaceuticals
Palivizumab (Synagis) is indicated for the prevention of serious lower respiratory tract disease requiring hospitalization caused by respiratory syncytial virus
Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity
Apollo's unparalleled clinical excellence is built on extensive experience of performing over 300,000 angioplasties and 200,000 cardiac surgeries
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
‘Sanjeevani’ aims to raise awareness and encourage conversations around the silent cancer epidemic
India is promoting holistic healthcare with emphasis on preventive care
Also to be launched Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP)
30 beneficiaries avail of services per minute
Subscribe To Our Newsletter & Stay Updated
